Eric Eldering

16PUBLICATIONS
72CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Liquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Oct 22, 2026
A role for eIF5A in translational control of stress-inducible proteins in multiple myeloma cell lines.

|Oct 11, 2026
Necroptosis as a key player in cervical cancer progression and management: a systematic review and transcriptomic cross-study consensus analysis.

|Jun 25, 2026
Necroptotic cell death and immunomodulator release induced by T-cell engaging anti-lymphoma therapies.

|Jun 11, 2025
Disruption of constitutive CXCR4 oligomers impairs oncogenic properties in lymphoid neoplasms.

Simon Mobach, Nick D Bergkamp, Ziliang Ma

|Mar 03, 2025
Cholesterol homeostasis and lipid raft dynamics at the basis of tumor-induced immune dysfunction in chronic lymphocytic leukemia.

Chaja F Jacobs, Fleur S Peters, Elena Camerini

|Jan 25, 2025
Longitudinal omics data and preclinical treatment suggest the proteasome inhibitor carfilzomib as therapy for ibrutinib-resistant CLL.

Lavinia Arseni, Gianluca Sigismondo, Haniyeh Yazdanparast

Pageof 3

Frequent Collaborators

11 joint publications

Arnon P Kater

5 joint publications

Fleur S Peters

4 joint publications

Marco Vincent Haselager

3 joint publications

Marcel Spaargaren